IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)

NARecruitingINTERVENTIONAL
Enrollment

498

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
StrokeStroke, Acute IschemicIntracranial Atherosclerosis
Interventions
PROCEDURE

Intracranial stenting

Intracranial stenting (+/- balloon dilatation) will be performed. Decisions regarding intracranial stenting are solely made by the treating physician. This means in specific, that the treating physician decides based on his/her judgement or based on local standards (as reported in the literature) on the devices and/or concomitant medications (including infusion/administration of antiplatelet medicine) used for intracranial stenting.

PROCEDURE

Continuation of conventional endovascular therapy (EVT)

Patients undergo either (a) continued stent retriever or contact aspiration based endovascular treatment manoeuvres, (b) infusion/administration of antiplatelet medication or (c) stop of the procedure depending on local standard treatment approaches.

Trial Locations (1)

4031

RECRUITING

University Hospital Basel, Department of Interventional and Diagnostical Neuroradiology, Basel

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

Acandis GmbH

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER

NCT06472336 - IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS) | Biotech Hunter | Biotech Hunter